High level expression of recombinant human kallistatin in Pichia pastoris and its bioactivity

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 26, Issue 2, 2010, Pages 249-255

  Huang, Xiaoping ^a   Wang, Xiao ^a   Dong, Hao ^a   Zhao, Xiaofeng ^a   Li, Zhaofa ^a   Wang, Qizhao ^a   Xu, Ruian ^a   Diao, Yong ^a  

^a HUAQIAO UNIVERSITY   (China)

Author keywords

Activity; Expression; Kallistatin; Pichia pastoris

Indexed keywords

ANTIOXIDANT; COMPLEMENTARY DNA; KALLISTATIN; RECOMBINANT PROTEIN; SERINE PROTEINASE INHIBITOR;

ARTICLE; BIOSYNTHESIS; ELECTROPORATION; GENE VECTOR; GENETICS; HUMAN; METABOLISM; PICHIA;

ANTIOXIDANTS; DNA, COMPLEMENTARY; ELECTROPORATION; GENETIC VECTORS; HUMANS; PICHIA; RECOMBINANT PROTEINS; SERPINS;

PICHIA PASTORIS;

EID: 77954768718     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chao J, Chao L, Robert Q, et al. Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling. Bio Chem, 2001, 382(1): 15-21.
2. Chao J, Chao L, John N, et al. Kallistatin is a potent new vasodilator. J Clin Invest, 1997, 100(1): 11-17.
3. Miao RQ, Murakami H, Song Q, et al. Kallistatin stimulates vascular smooth muscle cell proliferation and migration in vitro and neointima formation in balloon-injured rat artery. Circ Res, 2000, 86(4): 418-424.
4. Chao J, Yin H, Chao L, et al. Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation. Hum Gen Ther, 2006, 17(12): 1201-1213.
5. Shen B, Chao J, Hagiwara M, et al. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension, 2008, 51(5): 1358-1365.
6. Miao RQ, Agata J, Chao L, et al. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood, 2002, 100(9): 3245-3252.
7. Wang MY, Day J, Chao L, et al. Human kallistatin, a new tissue kallikrein-binding protein: purification and characterization. Adv Exp Med Biol, 1989, 247: 1-8.
8. Chai KX, Chen LM, Chao J, et al. Kallistatin: a novel human serine proteinase inhibitor. Molecular cloning, tissue distribution and expression in Escherichia coli. J Biol Chem, 1993, 268(32): 24498-24505.
9. Diao Y, Ma J, Xiao WD, et al. Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin. World J Gastroenterol, 2007, 13(34): 4615-4619.
10. Tse LY, Xu RA, Sun XY, et al. Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas. J Gene Med, 2008, 10(5): 508-517.
11. Zhao X, Huo KK, Li YY. Synonymous codon usage in Pichia pastoris. Chin J Biotech, 2000, 16(3): 308-312.
12. Diao Y, Xu RA. Protocols of Cellular and Molecular Biotechnology. Beijing: Chemical Industry Press, 2008: 208-216.
13. Ye Q, Qin SK, Yin XJ, et al. Effect of Endostar on angiogenesis and inhibition of angiogenesis induced by liver cancer. China Pres Drug, 2008, 9(78): 81-81.
14. Gao L, Yin H, Smith S, et al. Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction. Lab Invest, 2008, 88(11): 1157-1166.
15. Mates JM, Sanchez-Jimenez FM. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol, 2000, 32(2): 157-170.
16. Locigno R, Castronovo V. Reduced glutathione system: role in cancer development, prevention and treatment. Int J Oncol, 2001, 19(2): 221-236.